Geron Plans to Discontinue Late-Stage Rytelo Trial After Efficacy Concerns

Photo: TokenPost
Geron shares fell more than 20% Wednesday as the company moved to end the study.
Source: TokenPost
An independent desk covering Stake, the US casino market and crypto.

Photo: TokenPost
Geron shares fell more than 20% Wednesday as the company moved to end the study.
Source: TokenPost